BMS / Mirati Therapeutics
BMS / Mirati Therapeutics is a US-approved specialty pharmaceutical manufacturer. Reserve Meds supports cross-border NPP access to BMS / Mirati Therapeutics products.
Drugs from BMS / Mirati Therapeutics supported via NPP
| Brand | Generic | Category | Indication |
|---|---|---|---|
| Krazati | adagrasib | Oncology (KRAS) | KRAS G12C‑mutated cancers |
How NPP access to BMS / Mirati Therapeutics products works
Reserve Meds sources BMS / Mirati Therapeutics products from DSCSA-compliant US specialty wholesalers, not from parallel-import channels. All supply is US-FDA-provenance.
Not affiliated with BMS / Mirati Therapeutics
Reserve Meds is an independent NPP operator. We are not a subsidiary, affiliate, or authorised distributor of BMS / Mirati Therapeutics.